{"id":"https://openalex.org/W4389839680","doi":"https://doi.org/10.1016/j.clgc.2023.12.008","title":"Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer","display_name":"Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer","publication_year":2023,"publication_date":"2023-12-16","ids":{"openalex":"https://openalex.org/W4389839680","doi":"https://doi.org/10.1016/j.clgc.2023.12.008","pmid":"https://pubmed.ncbi.nlm.nih.gov/38185609"},"language":"en","primary_location":{"id":"doi:10.1016/j.clgc.2023.12.008","doi":"https://doi.org/10.1016/j.clgc.2023.12.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clgc.2023.12.008","pdf_url":"http://www.clinical-genitourinary-cancer.com/article/S1558767323002744/pdf","source":{"id":"https://openalex.org/S71328803","display_name":"Clinical Genitourinary Cancer","issn_l":"1558-7673","issn":["1558-7673","1938-0682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Genitourinary Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.clinical-genitourinary-cancer.com/article/S1558767323002744/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007368748","display_name":"Chitra Priya Emperumal","orcid":"https://orcid.org/0000-0002-9208-9406","observed_orcids":["https://orcid.org/0000-0002-9208-9406"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Chitra Priya Emperumal","raw_affiliation_strings":["Department of Orofacial Sciences, University of California San Francisco, San Francisco, CA. Electronic address: chitrapriya.emperumal@ucsf.edu","Department of Orofacial Sciences, University of California San Francisco, San Francisco California"],"raw_orcid":"https://orcid.org/0000-0002-9208-9406","affiliations":[{"raw_affiliation_string":"Department of Orofacial Sciences, University of California San Francisco, San Francisco, CA. Electronic address: chitrapriya.emperumal@ucsf.edu","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Department of Orofacial Sciences, University of California San Francisco, San Francisco California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061963925","display_name":"Alessandro Villa","orcid":"https://orcid.org/0000-0002-1966-6000","observed_orcids":["https://orcid.org/0000-0002-1966-6000"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210097785","display_name":"Baptist Health South Florida","ror":"https://ror.org/00v47pv90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210097785"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alessandro Villa","raw_affiliation_strings":["Department of Orofacial Sciences, University of California San Francisco, San Francisco, CA; Oral Medicine, Oral Oncology and Dentistry, Miami Cancer Institute, Baptist Health South Florida, Miami, FL","Department of Orofacial Sciences, University of California San Francisco, San Francisco California","Oral Medicine, Oral Oncology and Dentistry, Miami Cancer Institute, Miami, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Orofacial Sciences, University of California San Francisco, San Francisco, CA; Oral Medicine, Oral Oncology and Dentistry, Miami Cancer Institute, Baptist Health South Florida, Miami, FL","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210097785"]},{"raw_affiliation_string":"Department of Orofacial Sciences, University of California San Francisco, San Francisco California","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Oral Medicine, Oral Oncology and Dentistry, Miami Cancer Institute, Miami, Florida","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060394710","display_name":"Caleb Hwang","orcid":"https://orcid.org/0009-0005-1986-8357","observed_orcids":["https://orcid.org/0009-0005-1986-8357"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caleb Hwang","raw_affiliation_strings":["Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA","Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California"],"raw_orcid":"https://orcid.org/0009-0005-1986-8357","affiliations":[{"raw_affiliation_string":"Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058893054","display_name":"David Yoonsuk Oh","orcid":"https://orcid.org/0000-0002-3310-0994","observed_orcids":["https://orcid.org/0000-0002-3310-0994"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Oh","raw_affiliation_strings":["Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA","Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California","Division of Hematology/Oncology, University of California San Francisco, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of California San Francisco, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073970384","display_name":"Lawrence H. Fong","orcid":"https://orcid.org/0000-0002-6428-428X","observed_orcids":["https://orcid.org/0000-0002-6428-428X"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence Fong","raw_affiliation_strings":["Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA","Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California","Division of Hematology/Oncology, University of California San Francisco, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of California San Francisco, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081123075","display_name":"Rahul Raj Aggarwal","orcid":"https://orcid.org/0000-0001-7003-7982","observed_orcids":["https://orcid.org/0000-0001-7003-7982"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rahul Aggarwal","raw_affiliation_strings":["Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA","Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California","Division of Hematology/Oncology, University of California San Francisco, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of California San Francisco, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007692663","display_name":"Bridget P. Keenan","orcid":"https://orcid.org/0000-0001-6075-489X","observed_orcids":["https://orcid.org/0000-0001-6075-489X"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bridget P. Keenan","raw_affiliation_strings":["Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA","Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California","Division of Hematology/Oncology, University of California San Francisco, San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0001-6075-489X","affiliations":[{"raw_affiliation_string":"Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"Cancer Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of California San Francisco, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5007368748"],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":{"value":3580,"currency":"USD","value_usd":3580},"apc_paid":{"value":3580,"currency":"USD","value_usd":3580},"fwci":1.4666,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.83399515,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":98},"biblio":{"volume":"22","issue":"2","first_page":"380","last_page":"384"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12198","display_name":"Oral health in cancer treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12198","display_name":"Oral health in cancer treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13761","display_name":"HIV/AIDS oral health manifestations","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oral-toxicity","display_name":"oral toxicity","score":0.6600000262260437},{"id":"https://openalex.org/keywords/xerostomia","display_name":"xerostomia","score":0.9729999899864197},{"id":"https://openalex.org/keywords/dysgeusia","display_name":"dysgeusia","score":0.9610000252723694},{"id":"https://openalex.org/keywords/mucositis","display_name":"mucositis","score":0.9290000200271606},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.8579999804496765},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.9399999976158142},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.800000011920929},{"id":"https://openalex.org/keywords/oral-complications","display_name":"oral complications","score":0.3959999978542328},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.8370000123977661},{"id":"https://openalex.org/keywords/on-target-off-tumor-toxicity","display_name":"on-target off-tumor toxicity","score":0.5270000100135803},{"id":"https://openalex.org/keywords/on-target-toxicity","display_name":"on-target toxicity","score":0.7960000038146973},{"id":"https://openalex.org/keywords/dry-throat","display_name":"dry throat","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9372424483299255},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7793641686439514},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5417677760124207},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4698551893234253},{"id":"https://openalex.org/C2781114028","wikidata":"https://www.wikidata.org/wiki/Q6746708","display_name":"Management of prostate cancer","level":4,"score":0.4498976767063141},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44591641426086426},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.4398159682750702},{"id":"https://openalex.org/C2909289247","wikidata":"https://www.wikidata.org/wiki/Q1143025","display_name":"Oral Cancers","level":3,"score":0.4247582256793976},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40380311012268066}],"mesh":[{"descriptor_ui":"D004151","descriptor_name":"Dipeptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004408","descriptor_name":"Dysgeusia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014987","descriptor_name":"Xerostomia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052016","descriptor_name":"Mucositis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.clgc.2023.12.008","doi":"https://doi.org/10.1016/j.clgc.2023.12.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clgc.2023.12.008","pdf_url":"http://www.clinical-genitourinary-cancer.com/article/S1558767323002744/pdf","source":{"id":"https://openalex.org/S71328803","display_name":"Clinical Genitourinary Cancer","issn_l":"1558-7673","issn":["1558-7673","1938-0682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Genitourinary Cancer","raw_type":"journal-article"},{"id":"pmid:38185609","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38185609","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical genitourinary cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.clgc.2023.12.008","doi":"https://doi.org/10.1016/j.clgc.2023.12.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clgc.2023.12.008","pdf_url":"http://www.clinical-genitourinary-cancer.com/article/S1558767323002744/pdf","source":{"id":"https://openalex.org/S71328803","display_name":"Clinical Genitourinary Cancer","issn_l":"1558-7673","issn":["1558-7673","1938-0682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Genitourinary Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320311624","display_name":"American Academy of Sleep Medicine","ror":"https://ror.org/0090hd978"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389839680.pdf","grobid_xml":"https://content.openalex.org/works/W4389839680.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W2000915744","https://openalex.org/W2045720696","https://openalex.org/W2064272625","https://openalex.org/W2099706887","https://openalex.org/W2102681606","https://openalex.org/W2103959341","https://openalex.org/W2120292596","https://openalex.org/W2123526148","https://openalex.org/W2133298966","https://openalex.org/W2236959863","https://openalex.org/W2408097265","https://openalex.org/W2466387665","https://openalex.org/W2783137027","https://openalex.org/W2790934354","https://openalex.org/W2794577178","https://openalex.org/W2902659022","https://openalex.org/W2937483840","https://openalex.org/W2967884832","https://openalex.org/W3008868359","https://openalex.org/W3028523516","https://openalex.org/W3087866938","https://openalex.org/W3107641750","https://openalex.org/W3130934287","https://openalex.org/W3162612789","https://openalex.org/W3176208875","https://openalex.org/W3184088459","https://openalex.org/W4213049486","https://openalex.org/W4293778942","https://openalex.org/W4309889967","https://openalex.org/W4320896665","https://openalex.org/W4328095977","https://openalex.org/W4365446410","https://openalex.org/W4385302690","https://openalex.org/W4388089396"],"related_works":["https://openalex.org/W4414919758","https://openalex.org/W4407701789","https://openalex.org/W4404205938","https://openalex.org/W3042223461","https://openalex.org/W4400412422","https://openalex.org/W7162690613","https://openalex.org/W3162612789","https://openalex.org/W6907565113","https://openalex.org/W4293778942","https://openalex.org/W2808022995"],"abstract_inverted_index":{"Introduction":[0],"PSMA":[1],"(Prostate":[2],"Specific":[3],"Membrane":[4],"Antigen)-targeted":[5],"radionucleotide":[6],"therapy":[7],"has":[8],"been":[9,24],"shown":[10],"to":[11,33,96,242,262,300,332,340],"cause":[12,292],"dry":[13,129,181,293,321],"mouth,":[14,322],"but":[15],"the":[16,37,54,72,79,98,119,169,184,270,305,314,329],"oral":[17,38,73,121,224,265,273,279,284,306,337,343],"manifestations":[18,39],"of":[19,29,40,56,71,75,78,104,186,234,272,283,308,317,335],"PSMA-targeted":[20,41,76,109,210,309,318],"immunotherapy":[21],"have":[22],"not":[23,147,203],"extensively":[25],"studied.":[26],"The":[27],"aim":[28],"this":[30],"study":[31,237],"was":[32,153,197,202],"describe":[34],"and":[35,64,90,113,131,144,158,220,228,251,281,324,339],"quantify":[36],"immunotherapies":[42,77,110,211,261,319],"(bispecific":[43],"antibodies":[44],"or":[45],"CAR":[46],"(Chimeric":[47],"Antigen":[48],"Receptor)":[49],"T":[50],"cell":[51],"therapies)":[52],"in":[53,134,149,167,346],"management":[55,282],"metastatic":[57],"castration":[58],"resistant":[59],"prostate":[60,213,256],"cancer":[61,86,214,257],"(mCRPC).":[62],"Patients":[63,207],"Methods":[65],"We":[66,311,326],"performed":[67],"a":[68,83,102,240,247,277],"retrospective":[69],"analysis":[70],"toxicities":[74,225,307,338],"patients":[80,106,116,170,258],"seen":[81],"at":[82,183],"single":[84],"institution's":[85],"center":[87],"between":[88,111],"2020":[89,112],"2023.":[91],"Descriptive":[92],"statistics":[93],"were":[94,146],"used":[95],"summarize":[97],"data.":[99],"Results":[100],"In":[101],"total":[103],"19":[105],"treated":[107,208],"with":[108,155,191,209,217,246,259],"2023,":[114],"9":[115],"(47%)":[117],"experienced":[118],"following":[120],"toxicities:":[122],"xerostomia":[123,227],"(n=6;":[124],"32%),":[125],"mucositis":[126],"(n=2;10%),":[127],"dysgeusia,":[128,229,323],"throat":[130],"teeth":[132],"sensitivity":[133],"(n=1":[135],"each;":[136],"5%),":[137],"respectively.":[138],"Oral":[139],"infections,":[140],"such":[141],"as":[142,239],"candidiasis":[143],"herpes,":[145],"observed":[148],"any":[150],"patients.":[151],"Mucositis":[152],"managed":[154],"salt":[156],"rinses":[157],"resolved":[159],"within":[160],"few":[161],"months":[162],"from":[163],"onset.":[164],"Xerostomia":[165],"persisted":[166],"all":[168],"(median:":[171],"306":[172],"days,":[173],"range:":[174],"98-484":[175],"days)":[176],"among":[177],"those":[178],"who":[179],"reported":[180],"mouth":[182],"time":[185],"data":[187],"collection,":[188],"despite":[189],"treatment":[190],"salivary":[192],"stimulants":[193],"(n=5;":[194],"83%).":[195],"Dysgeusia":[196],"also":[198,252],"persistent,":[199],"although":[200],"it":[201],"specifically":[204],"treated.":[205],"Conclusions":[206],"for":[212,276,328],"can":[215,231,291],"present":[216],"various":[218],"short-term":[219],"long-term":[221],"off-tumor":[222],"on-target":[223],"including":[226],"that":[230,313],"affect":[232],"quality":[233],"life.":[235],"This":[236],"serves":[238],"foundation":[241],"future":[243],"prospective":[244],"studies":[245,299],"larger":[248],"sample":[249],"size":[250],"help":[253],"oncologists":[254],"managing":[255],"targeted":[260],"familiarize":[263],"common":[264],"toxicities.":[266],"Furthermore,":[267],"we":[268],"emphasize":[269],"importance":[271],"medicine":[274,344],"consultation":[275],"comprehensive":[278],"examination":[280],"complications.":[285],"Micro":[286],"Abstract":[287],"PSMA-directed":[288],"radioligand":[289],"therapies":[290],"mouth;":[294],"however,":[295],"there":[296],"are":[297],"no":[298],"date":[301],"focusing":[302],"exclusively":[303],"on":[304],"immunotherapies.":[310],"found":[312],"adverse":[315],"effects":[316],"included":[320],"mucositis.":[325],"advocate":[327],"oncology":[330],"community":[331],"be":[333],"aware":[334],"potential":[336],"consider":[341],"involving":[342],"specialists":[345],"patient":[347],"care.":[348]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-12-17T00:00:00"}